LBPH Longboard Pharmaceuticals Inc Total Business Assets
This chart of Longboard Pharmaceuticals (LBPH) total asset value history on the GURU.Markets platform is 177.91. Longboard Pharmaceuticals management effectively invests capital into developing drugs for orphan brain pathologies. A developed network of specialized warehouses ensures the stability of critical component supplies. Meanwhile, the operating model relies on engaging external research organizations, whose work is strictly monitored by regulators.
Analytical breakdowns and data insights for company Longboard Pharma (LBPH)
- stock price and consensus target price:
- market capitalization data:
- book capitalization information:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Longboard Pharmaceuticals|LBPH - Long-Term Debt to Equity|Current Liabilities to Capital Longboard|LBPH - Company Debts|Debt to Book Capitalization Ratio Longboard|LBPH - Company Long-Term Debt|Short-Term Debt Longboard Pharmaceuticals|Immediate Liquidity Ratio longboardpharma.com
- company profitability and valuation multiples indicators:
Basic company analysis:longboardpharma.com, LBPH
Striving for leadership in the therapy of rare neurological pathologies, Longboard Pharmaceuticals (LBPH) is actively accumulating resources, which is reflected in the dynamics of its total assets. This metric, calculated inversely via ROA, sums equity and liabilities, allowing investors to assess the scale of the material base and the extent to which the development of the company's technological potential depends on attracted debt financing.
Main competitors
biogen.com - Aggregate Asset Value|Aggregate Company Assets Neurocrine Biosciences, Inc.|Total Business Assets RGC (Regencell Bioscience Ltd)|Company Total Assets AXSM|ACAD - Company Assets|Xenon Pharmaceuticals - Cumulative Company Assets|Company Total Assets vikingtherapeutics.com VKTX|SUPN - Aggregate Company Assets|Aggregate Asset Value CPRX (Catalyst Pharma)|Denali Therapeutics Inc (DNLI) - Aggregate Company Assets|Company Assets Harmony Corp (HRMY)|Aggregate Company Assets Biohaven Ltd.|Aggregate Company Assets AMLX|Aggregate Company Assets Trevi Therapeutics, Inc. (TRVI)|PRAX - Company Assets|Aggregate Company Assets Anavex Corp AVXL|CBLL: Total Business Assets|Prothena Corporation plc - Company Total Assets|Company Balance Sheet Assets Alector, Inc. (ALEC)|ANNX: Company Total Assets|OMER (Omeros) - Aggregate Company Assets|Aggregate Company Assets Neurogene Corp|Company Assets AC Immune Inc ACIU|Company Total Assets VYGR|Company Total Assets neumoratx.com (NMRA)|Aggregate Company Assets Scilex SCLX|Aggregate Asset Value TVGN|Alpha Cognition Corp - Company Total Assets|CGTX (Cognition Therapeutics Inc.) - Total Business Assets|IKT (Inhibikase Therapeutics) - Cumulative Company Assets|cassavasciences.com - Aggregate Asset Value|Aggregate Company Assets Assertio Holdings|Coya - Total Asset Value of Company|Company Total Assets VTGN|OVID (ovidrx.com) - Aggregate Asset Value|Company Total Assets ABOS (Acumen Pharmaceuticals)|Company Total Assets cervomed.com CRVO|ATHE - Aggregate Company Assets|Aggregate Asset Value CLNN (Clene Inc.)|pepgen.com (PEPG) - Aggregate Company Assets|Cumulative Company Assets Jupiter Neurosciences, Inc.|RLMD (Relmada Therapeutics) - Company Total Assets|Company Total Assets annovisbio.com|Company Total Assets GRCE|Cumulative Company Assets Firefly Neuroscience, Inc. AIFF|Company Total Assets KLTO (Klotho Neurosciences)|NeuroSense Therapeutics Ltd (NRSN) - Company Assets|RVPH: Cumulative Company Assets|MTVA - Company Total Assets|NRXS (NeurAxis) - Cumulative Company Assets|HSDT: Aggregate Business Assets|PASG (Passage Bio Inc.) - Company Total Assets|Neuphoria (NEUP) - Company Total Asset Base|Company Total Assets NERV|Cumulative Company Assets athira.com ATHA|Company Total Assets ADXN (Addex Therapeutics Ltd)|Company Total Assets Alzamend Neuro Inc. ALZN|CYCN - Aggregate Company Assets|PTIX: Aggregate Company Assets|pasitheaclinics.com (KTTA) - Aggregate Company Assets|CRGT - Company Total Asset Base|Aggregate Company Assets Avenue Therapeutics, Inc.|Aggregate Company Assets BCLI|Company Total Assets CARA|Aggregate Company Assets CHRO (Chromocell)|Aggregate Company Assets Eliem Therapeutics Inc. ELYM|ITCI (Intra-Cellular Therapies Inc.) - Total Asset Value of Company|Marinus Pharmaceuticals, Inc. - Company Total Assets|Aggregate Asset Value NKGN (NKGen Biotech Inc)|NeuroBo (NRBO) - Aggregate Company Assets|Total Business Assets SAGE|SNPX (Synaptogenix, Inc.) - Company Total Assets|Company Assets trevena.com TRVN|Cumulative Company Assets VIGL (Vigil Neuroscience)|Company Total Assets anewmeds.com (WENA)|Aggregate Company Assets Cerevel CERE